Bigfoot Biomedical

Info

Contact Jeffrey Brewer
Title President & CEO

Description

A startup founded by people with a personal connection to Type 1 Diabetes, the team boasts of nearly 400 years of living with T1D. Using a proprietary Bluetooth-enabled insulin pump that will connect to the next generation of Abbott’s category-defining FreeStyle® Libre CGM and a smartphone mobile app, Bigfoot Loop is a closed loop automated insulin delivery system for which the company has completed initial clinical trials. They’re preparing now for a pivotal trial in the US, anticipated to begin later this year at sites around the country. In parallel, Bigfoot is developing Bigfoot Inject, a Bluetooth-connected insulin pen solution for injection users that will use the same CGM and a mobile app to track and titrate basal and mealtime insulin doses. Both products are intended to be delivered as a monthly subscription service supported by auto-fulfillment of consumable supplies.

Company News

Bigfoot Scores FDA Clearance for Diabetes Management System

/
DateMay 12, 2021
Bigfoot Biomedical is a company that MD+DI readers should be quite familiar with by now. In 2017, the diabetes company was selected as the readers' choice for Medtech Company of the Year. The company is developing products to optimize insulin dosing and provide automated insulin delivery for people with insulin-requiring diabetes.
Read More →

Bigfoot Biomedical® Secures up to $57 Million in Combined Debt and Equity Financing from Madryn Asset Management

/
DateMar 17, 2021
Bigfoot Biomedical, a company dedicated to better health outcomes for people with insulin-requiring diabetes, announced today that it has secured new financing of up to $57 million from Madryn Asset Management LP, an alternative asset management firm focused on investments in innovative health care companies.
Read More →

Bigfoot Biomedical raises $55m in Series C

/
DateJun 3, 2020
Milpitas, Calif.-based Bigfoot said in a news release that the proceeds will support product development and the regulatory pathway for its Bigfoot Unity system as a part of the Bigfoot Unity Diabetes Management Program.
Read More →